Agalimmune
Agalimmune focuses on developing an anti-cancer immunotherapy technology for the treatment of patients with solid tumors.
Business Model:
Revenue: $2M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Agalimmune Information
Agalimmune was acquired by
BiolineRx.
The acquisition happend on 2017-03-23.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 6 Arlington Street
City: London
State: england
Zip: SW1A 1RE
Country: GB
Financial Info
Stage:
Raised Last:
$0
Raised Total:$2M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Agalimmune focuses on developing an anti-cancer immunotherapy technology for the treatment of patients with solid tumors.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2014 | Debt | $2M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
